| VASVX | VMVIX | VASVX / VMVIX | |
| Total Expense Ratio | 0.42 | 0.19 | 221% |
| Annual Report Gross Expense Ratio | 0.42 | 0.19 | 221% |
| Fund Existence | 30 years | 19 years | - |
| Gain YTD | -0.591 | 10.973 | -5% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 3000 | 3000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 6.35B | 32.6B | 19% |
| Annual Yield % from dividends | 1.63 | 2.02 | 81% |
| Returns for 1 year | -1.18 | 9.73 | -12% |
| Returns for 3 years | 8.03 | 33.21 | 24% |
| Returns for 5 years | 4.47 | 53.81 | 8% |
| Returns for 10 years | 3.00 | 110.07 | 3% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SPVU | 57.36 | 0.27 | +0.48% |
| Invesco S&P 500® Enhanced Value ETF | |||
| NBB | 15.74 | 0.07 | +0.45% |
| Nuveen Taxable Municipal Income Fund | |||
| RJMG | 27.53 | 0.09 | +0.33% |
| FT Raymond James Multcp Gr Eq ETF | |||
| IHI | 62.73 | 0.09 | +0.14% |
| iShares US Medical Devices ETF | |||
| FEBU | 27.93 | N/A | N/A |
| AllianzIM U.S. Equity Buffer15 UncFebETF | |||